Source: Eclipsebio Blog

Eclipsebio Blog RNA structure analysis for improved drug development

RNA secondary structure is a key determinant of RNA biology and therapeutic efficacy. In this eBlog, we review how RNA structure affects the development of RNA vaccines, siRNAs, and ASOs. The post RNA structure analysis for improved drug development first appeared on Eclipsebio.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Peter Chu's photo - Co-Founder & CEO of Eclipsebio

Co-Founder & CEO

Peter Chu

CEO Approval Rating

90/100

Read more